The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates
Open accessAbstract
In acute inflammation, extracellular ATP activates P2X(7) ion channel receptors (P2X(7)R) on M1 polarized macrophages to release pro-inflammatory IL-1beta through activation of the caspase-1/nucleotide-binding domain and leucine-rich repeat receptor containing pyrin domain 3 (NLRP3) inflammasome. In contrast, M2 polarized macrophages are critical to the resolution of inflammation but neither actions of P2X(7)R on these macrophages nor mechanisms by which macrophages switch from pro-inflammatory to anti-inflammatory phenotypes are known. Here, we investigated extracellular ATP signalling over a dynamic macrophage polarity gradient from M1 through M2 phenotypes. In macrophages polarized towards, but not at, M2 phenotype, in which intracellular IL-1beta remains high and the inflammasome is intact, P2X(7)R activation selectively uncouples to the NLRP3-inflammasome activation but not to upstream ion channel activation. In these intermediate M1/M2 polarized macrophages, extracellular ATP now acts through its pyrophosphate chains, independently of other purine receptors, to inhibit IL-1beta release by other stimuli through two independent mechanisms: inhibition of ROS production and trapping of the inflammasome complex through intracellular clustering of actin filaments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 1×
“IL-1b processing and release is a tightly regulated process involving a multiprotein complex, the capase-1 inflammasome (Martinon et al, 2002).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080 · cited 9×
“In agreement with numerous stu- dies (Mariathasan et al, 2006; Pelegrin and Surprenant, 2006, 2007; Pétrilli et al, 2007), both P2X7R and E. coli stimulation induced the release of IL-1b from M1 polarized macrophages but P2X7R-induced release of IL-1b was significantly reduced, or absent, in…”
BackgroundMethodInfluentialHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445 · cited 3×
“…of all known purine and adenosine receptors except for P2X7R; indeed, the IC50 value for ATP inhibition of MTX-induced IL-1b release in P2X7R-depleted macrophage (1.54±0.03 mM, n¼ 3) was not significantly different from the ATP EC50 value to induce release of IL-1b from wild-type M1 macrophages”
BackgroundResultInfluentialPannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrin, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,431
Self-citationRussell, R. G. G., Watts, N. B., Ebetino, F. H., & Rogers, M. J. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0540-8 · Cited by 1,411
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3
Kanneganti, T.-D., Özören, N., Body-Malapel, M., Amer, A., Park, J.-H., Franchi, L., Whitfield, J., Barchet, W., Colonna, M., Vandenabeele, P., et al. (2006) · Nature · doi:10.1038/nature04517 · Cited by 1,148
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
Extracellular metabolism of ATP and other nucleotides
Zimmermann, H. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000309 · Cited by 990
Macrophage activation switching: an asset for the resolution of inflammation
Porcheray, F., Viaud, S., Rimaniol, A.-C., Léone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., & Gras, G. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02934.x · Cited by 840 · cited 1×
“However, only recently it has begun to be appreciated that macrophages are able to reversibly and dynamically switch from one activation state to the other (Stout and Suttles, 2004; Porcheray et al, 2005; Gratchev et al, 2006).”
BackgroundT-cell subsets (Th1 versus Th2)
Romagnani, S. (2000) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62426-x · Cited by 815
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 789
Functional plasticity of macrophages: reversible adaptation to changing microenvironments
Stout, R. D., & Suttles, J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504272 · Cited by 751
Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response
Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., Brissette, W., Wicks, J. R., Audoly, L., & Gabel, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6436 · Cited by 490
Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T. R., Gaasterland, T., Schoolnik, G., & Nathan, C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1123 · Cited by 459
Honore, P., Donnelly-Roberts, D., Namovic, M. T., Hsieh, G., Zhu, C. Z., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111559 · Cited by 414
P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage
Pelegrin, P., Barroso-Gutierrez, C., & Surprenant, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7147 · Cited by 410
Self-citationPelegrin, P., & Surprenant, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610351200 · Cited by 302
Self-citationCaspase-1-dependent processing of pro-interleukin-1β is cytosolic and precedes cell death
Brough, D., & Rothwell, N. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.03377 · Cited by 265
Pennanen, N., Lapinjoki, S., Urtti, A., & Mönkkönen, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016281608773 · Cited by 211
Gratchev, A., Kzhyshkowska, J., Köthe, K., Muller-Molinet, I., Kannookadan, S., Utikal, J., & Goerdt, S. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.017 · Cited by 193
Elimination, blocking, and activation of macrophages: three of a kind?
van Rooijen, N., & Sanders, A. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.6.702 · Cited by 162
Pfeiffer, Z. A., Aga, M., Prabhu, U., Watters, J. J., Hall, D. J., & Bertics, P. J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203648 · Cited by 159
Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1β System by IL-13
Scotton, C. J., Martínez, F. O., Smelt, M. J., Sironi, M., Locati, M., Mantovani, A., & Sozzani, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.834 · Cited by 143
A Key Role for Redox Signaling in Rapid P2X7 Receptor-Induced IL-1β Processing in Human Monocytes
Hewinson, J., Moore, S., Glover, C., Watts, A. G., & Mackenzie, A. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8410 · Cited by 124
IL-1 beta production in cultured human monocytes is regulated at multiple levels.
Arend, W. P., Gordon, D. F., Wood, W. M., Janson, R. W., Joslin, F. G., & Jameel, S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.118 · Cited by 69
Targeting Interleukin-1 Signaling in Chronic Inflammation: Focus on P2X7 Receptor and Pannexin-1
Pelegrín, P. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.8.1265800 · Cited by 66
Maitotoxin Induces Biphasic Interleukin-1β Secretion and Membrane Blebbing in Murine Macrophages
Verhoef, P. A., Kertesy, S. B., Estación, M., Schilling, W. P., & Dubyak, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.4.909 · Cited by 47
Shen, D., Liang, X., Gawinowicz, M. A., & Gottesman, M. M. (2004) · PubMed · doi:10.1124/mol.66.4 · Cited by 33
Effect of Purine Nucleoside Phosphates on OH-Radical Generation by Reaction of Fe2+With Oxygen
Kachur, A. V., Manevich, Y., & Biaglow, J. E. (1997) · Free Radical Research · doi:10.3109/10715769709084476 · Cited by 30
Antioxidant effect of bisphosphonates and simvastatin on chondrocyte lipid peroxidation
Dombrecht, E. J., Tollenaere, C. B. D., Aerts, K., Cos, P., Schuerwegh, A. J., Bridts, C. H., Offel, J. F. V., Ebo, D. G., Stevens, W. J., & Clerck, L. S. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.075 · Cited by 24
Serretti, R., Core, P., Muti, S., & Salaffi, F. (1993) · Rheumatology International · doi:10.1007/bf00301259 · Cited by 16
Cited by
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Understanding the mechanism of IL-1β secretion
Lopez-Castejon, G., & Brough, D. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.10.001 · Cited by 1,519
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
Tan, H.-Y., Wang, N., Li, S., Hong, M., Wang, X., & Feng, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2795090 · Cited by 657
Metadata
- Authors
- Pelegrin, P., & Surprenant, A.
- Venue
- The EMBO Journal
- Published
- 2009-06-18
- Volume
- 28
- Issue
- 14
- Pages
- 2114-2127
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2013471060
- Cited by
- 264
- References
- 40
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.